14 search results found
- June 22, 2020 | MIT News Office
Experimental peptide targets Covid-19
- March 27, 2020 | MIT News Office
An experimental peptide could block Covid-19
-
2023-Japan-Decoy Therapeutics
Broad-acting peptide conjugate antiviral platform -
4.28.23-Korea-Decoy-Therapeutics
Broad-acting peptide conjugate antiviral platform -
Past Deadline: Dec 31, 2020
P&G seeks startups for feminine care quality test automation
otherP&G is looking for partners and solutions that can support the automation of quality testing and preparation process at its Feminine Care manufacturing sites.
-
12.7.2022-Demo Day-Decoy Therapeutics
Broad-acting Peptide Conjugate Antiviral Platform
Barbara Hibner; Co-Founder and CSO, Decoy Therapeutics
-
Past Deadline: Aug 4, 2024
Speak at 2024 MITEI annual research conference
speakerThis year’s theme will be built around ensuring the durability of the energy transition in the face of future unknowns.
-
5.10.23-Ecosystem-Supporting-New-Ventures
Supporting New Ventures. The Ecosystem's Role -
Past Deadline: Feb 25, 2020
Anglo American seeking startups for February visit
meetingAnglo American, a British mining company, is looking for startups in bio technology, rapid access, improved recovery, dry processing, mining legacy, sensor fusion, and EPC disruption.
-
Decoy Therapeutics Inc.
Cambridge, MAThe 21st century is experiencing epidemics and pandemics with increasing frequency, and the world needs new tools to combat these diseases. Decoy's platform engineers new pan-viral drugs that address both existing and new zoonotic viral threats. Our lead antiviral nasal spray has demonstrated... MoreKeywords:
